Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
作者信息
Zegans M, Marsh B, Walton R C
机构信息
Section of Ophthalmology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
出版信息
Int Ophthalmol Clin. 2000 Spring;40(2):127-35. doi: 10.1097/00004397-200004000-00010.
Abstract
摘要
相似文献
1
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Int Ophthalmol Clin. 2000 Spring;40(2):127-35. doi: 10.1097/00004397-200004000-00010.
2
Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.
Br J Ophthalmol. 2001 Apr;85(4):381-2. doi: 10.1136/bjo.85.4.381.
3
Immune recovery uveitis.
Am J Ophthalmol. 2000 Jul;130(1):103-6. doi: 10.1016/s0002-9394(00)00537-7.
4
Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
Am J Ophthalmol. 2000 Jul;130(1):49-56. doi: 10.1016/s0002-9394(00)00530-4.
5
Management of cytomegalovirus retinitis in HIV infection in the era of highly active antiretroviral therapy.
Int J STD AIDS. 2015 Sep;26(10):757-8. doi: 10.1177/0956462415571374.
6
Exploring the benefits and limits of highly active antiretroviral therapy.
JAMA. 1999 Nov 3;282(17):1668-9. doi: 10.1001/jama.282.17.1668.
7
Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy.
Ophthalmol Clin North Am. 2002 Dec;15(4):529-36, viii. doi: 10.1016/s0896-1549(02)00048-2.
8
The double-edged ocular immune response: the Cogan lecture.
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3243-8.
9
Valganciclovir therapy for immune recovery uveitis complicated by macular edema.
Am J Ophthalmol. 2005 Jan;139(1):216-7; author reply 217. doi: 10.1016/j.ajo.2004.08.025.
10
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
JAMA. 2000 Feb 2;283(5):653-7. doi: 10.1001/jama.283.5.653.
Zotero 插件